Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 13, 2018 - Issue
Submit an article Journal homepage
78
Views
5
CrossRef citations to date
0
Altmetric
Review

New developments in optimizing bronchodilator treatment of COPD: a focus on glycopyrrolate/formoterol combination formulated by co-suspension delivery technology

Anthony D D’Urzo1 Department of Family and Community Medicine, Faculty of Medicine, University of Toronto, Toronto, ON, Canada, [email protected]Correspondence[email protected]
,
Mario Cazzola2 Department of Experimental Medicine and Surgery, Tor Vergata University of Rome, Rome, Italy
,
Nicola A Hanania3 Section of Pulmonary and Critical Care Medicine, Baylor College of Medicine, Houston, TX, USA
,
Roland Buhl4 Pulmonary Department, Mainz University Hospital, Mainz, Germany
&
M Reza Maleki-Yazdi5 Division of Respiratory Medicine, Women’s College Hospital, University of Toronto, Toronto, ON, Canada
Pages 2805-2819 | Published online: 07 Sep 2018

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Mario Cazzola, Francesco Cavalli, Omar S. Usmani & Paola Rogliani. (2020) Advances in pulmonary drug delivery devices for the treatment of chronic obstructive pulmonary disease. Expert Opinion on Drug Delivery 17:5, pages 635-646.
Read now

Articles from other publishers (4)

E. A. Orlova, I. P. Dorfman, M. A. Orlov & M. A. Abdullaev. (2022) The double bronchodilation era: new capabilities in a new drug delivery device. Meditsinskiy sovet = Medical Council:4, pages 128-137.
Crossref
Omar S. Usmani, Rajiv Dhand, Federico Lavorini & David Price. (2021) Why We Should Target Small Airways Disease in Our Management of Chronic Obstructive Pulmonary Disease. Mayo Clinic Proceedings 96:9, pages 2448-2463.
Crossref
Monika Chabicovsky, Swantje Winkler, Michael Soeberdt, Ana Kilic, Clarissa Masur & Christoph Abels. (2019) Pharmacology, toxicology and clinical safety of glycopyrrolate. Toxicology and Applied Pharmacology 370, pages 154-169.
Crossref
Mohd Kashif Siddiqui, Pragya Shukla, Martin Jenkins, Mario Ouwens, Deniz Guranlioglu, Patrick Darken & Mousumi Biswas. (2019) Systematic review and network meta-analysis of the efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler in comparison with other long-acting muscarinic antagonist/long-acting β 2 -agonist fixed-dose combinations in COPD . Therapeutic Advances in Respiratory Disease 13, pages 175346661989450.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.